Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Papillary”

361 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 361 results

Not applicableNot Yet RecruitingNCT07218315
What this trial is testing

Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
M.D. Anderson Cancer Center 15
Post-approval studies (Phase 4)UnknownNCT05247476
What this trial is testing

Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.

Who this might be right for
Thyroid Cancer, PapillaryHypothyroidism
Zhongshan Hospital Xiamen University 50
Not applicableStudy completedNCT06235814
What this trial is testing

Molecular Analysis for Precision Surgery in Thyroid Cancer Trial

Who this might be right for
Papillary Thyroid Cancer
University of California, Los Angeles 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT00295893
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 121
Not applicableUnknownNCT00984191
What this trial is testing

Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

Who this might be right for
Papillary Thyroid Cancer
Chulalongkorn University 15
Not applicableLooking for participantsNCT06133374
What this trial is testing

Concordance of Molecular Classification Based on Fine Needle Biopsy (FNB) and Surgical Samples

Who this might be right for
Papillary Thyroid Cancer
University of Calgary 130
Large-scale testing (Phase 3)Active Not RecruitingNCT05043090
What this trial is testing

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 148
Testing effectiveness (Phase 2)Study completedNCT01524926
What this trial is testing

CREATE: Cross-tumoral Phase 2 With Crizotinib

Who this might be right for
Locally Advanced and/or Metastatic Anaplastic Large Cell LymphomaLocally Advanced and/or Metastatic Inflammatory Myofibroblastic TumorLocally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1+3 more
European Organisation for Research and Treatment of Cancer - EORTC 582
Not applicableLooking for participantsNCT02757859
What this trial is testing

High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Acinar Cell CarcinomaAmpulla of Vater AdenocarcinomaCholangiocarcinoma+5 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 845
Early research (Phase 1)Active Not RecruitingNCT05122546
What this trial is testing

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Papillary Renal Cell CarcinomaAdvanced Renal Cell Carcinoma+9 more
City of Hope Medical Center 31
Not applicableActive Not RecruitingNCT03271892
What this trial is testing

Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer

Who this might be right for
Thyroid Cancer Stage I
University Health Network, Toronto 200
Testing effectiveness (Phase 2)Study completedNCT02761057
What this trial is testing

Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

Who this might be right for
Locally Advanced Papillary Renal Cell CarcinomaMetastatic Papillary Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+4 more
National Cancer Institute (NCI) 152
Not applicableLooking for participantsNCT06333587
What this trial is testing

Minimally Invasive Treatments of the Thyroid

Who this might be right for
Papillary Thyroid Microcarcinoma
European Institute of Oncology 270
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Not applicableEnded earlyNCT05014698
What this trial is testing

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

Who this might be right for
Differentiated Thyroid CancerThyroid Cancer, Nonmedullary
Nantes University Hospital 34
Not applicableStudy completedNCT01927887
What this trial is testing

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

Who this might be right for
Papillary Carcinoma of Thyroid GlandMetastatic Medullary Thyroid CancerFollicular Thyroid Cancer Lymph Node Metastasis
Massachusetts General Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00389441
What this trial is testing

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 52
Testing effectiveness (Phase 2)UnknownNCT05675605
What this trial is testing

TY-1091 in Patients With Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+1 more
TYK Medicines, Inc 248
Not applicableStudy completedNCT05132205
What this trial is testing

Radiofrequency Ablation of Papillary Thyroid Microcarcinoma

Who this might be right for
Papillary Thyroid Cancer
Johns Hopkins University 10
Testing effectiveness (Phase 2)Study completedNCT00729157
What this trial is testing

Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

Who this might be right for
Recurrent Thyroid Gland CarcinomaStage III Thyroid Gland Follicular CarcinomaStage III Thyroid Gland Papillary Carcinoma+2 more
National Cancer Institute (NCI) 41
Load More Results